ismp canada Vasopressor stewardship: A case report and lessons shared By Christine Koczmara, BSc, RN*, Charles St-Arnaud, MD*, Hector Quiroz Martinez, MD, Neill K.J. Adhikari, MSc, MD, Maureen O. Meade, MSc, MD, Dominic

First Page		Document Content
Date: 2014-03-31 14:26:21 Shock Sepsis Surviving Sepsis Campaign Early goal directed therapy Hypotension Phenylephrine Septic shock Antihypotensive agent Intensive-care medicine Medicine Intensive care medicine Medical emergencies		ismp canada Vasopressor stewardship: A case report and lessons shared By Christine Koczmara, BSc, RN, Charles St-Arnaud, MD, Hector Quiroz Martinez, MD, Neill K.J. Adhikari, MSc, MD, Maureen O. Meade, MSc, MD, Dominic Add to Reading List Source URL: www.ismp-canada.org Download Document from Source Website File Size: 126,24 KB Share Document on Facebook

	In D. Reitter & F. E. Ritter (Eds.), Proceedings of the 14th International Conference on Cognitive Modeling (ICCMUniversity Park, PA: Penn State. Effects of Guanfacine and Phenylephrine on a Spiking Neuron Model DocID: 1uIFb - View Document
	PROGRAMME DE SURVEILLANCE* 2016 Les substances ci-dessous sont incluses dans le programme de surveillance 2016 : 1. Stimulants : En compétition seulement : Bupropion, caféine, nicotine, phényléphrine, phénylpropanol DocID: 1qrJn - View Document
	Official Newsletter of the Utah Poison Control Center 2008 • Volume 10 • Issue 1 The University of Utah Utah Poison Control Center DocID: 1oyfz - View Document
	THE 2016 MONITORING PROGRAM* The following substances are placed on the 2016 Monitoring Program: 1. Stimulants: In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol and syneph DocID: 1nNeY - View Document
	THE 2016 MONITORING PROGRAM* The following substances are placed on the 2016 Monitoring Program: 1. Stimulants: In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol and syneph DocID: 1ne21 - View Document